AUTL
Price
$1.50
Change
-$0.07 (-4.46%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
417.84M
62 days until earnings call
SYBX
Price
$1.45
Change
-$0.00 (-0.00%)
Updated
Aug 29, 03:43 PM (EDT)
Capitalization
16.96M
Interact to see
Advertisement

AUTL vs SYBX

Header iconAUTL vs SYBX Comparison
Open Charts AUTL vs SYBXBanner chart's image
Autolus Therapeutics
Price$1.50
Change-$0.07 (-4.46%)
Volume$145.38K
Capitalization417.84M
Synlogic
Price$1.45
Change-$0.00 (-0.00%)
Volume$1.11K
Capitalization16.96M
AUTL vs SYBX Comparison Chart in %
Loading...
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AUTL vs. SYBX commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUTL is a Hold and SYBX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (AUTL: $1.57 vs. SYBX: $1.45)
Brand notoriety: AUTL and SYBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUTL: 129% vs. SYBX: 9%
Market capitalization -- AUTL: $417.84M vs. SYBX: $16.96M
AUTL [@Biotechnology] is valued at $417.84M. SYBX’s [@Biotechnology] market capitalization is $16.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUTL’s FA Score shows that 1 FA rating(s) are green whileSYBX’s FA Score has 0 green FA rating(s).

  • AUTL’s FA Score: 1 green, 4 red.
  • SYBX’s FA Score: 0 green, 5 red.
According to our system of comparison, AUTL is a better buy in the long-term than SYBX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUTL’s TA Score shows that 4 TA indicator(s) are bullish while SYBX’s TA Score has 5 bullish TA indicator(s).

  • AUTL’s TA Score: 4 bullish, 6 bearish.
  • SYBX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SYBX is a better buy in the short-term than AUTL.

Price Growth

AUTL (@Biotechnology) experienced а -10.29% price change this week, while SYBX (@Biotechnology) price change was +3.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.74%. For the same industry, the average monthly price growth was +15.52%, and the average quarterly price growth was +29.97%.

Reported Earning Dates

AUTL is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (-0.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUTL($418M) has a higher market cap than SYBX($17M). SYBX YTD gains are higher at: 3.571 vs. AUTL (-33.191). SYBX has higher annual earnings (EBITDA): -11.07M vs. AUTL (-232.19M). AUTL has more cash in the bank: 454M vs. SYBX (17M). SYBX has less debt than AUTL: SYBX (0) vs AUTL (64.5M). AUTL has higher revenues than SYBX: AUTL (29.9M) vs SYBX (0).
AUTLSYBXAUTL / SYBX
Capitalization418M17M2,459%
EBITDA-232.19M-11.07M2,098%
Gain YTD-33.1913.571-929%
P/E RatioN/A6.36-
Revenue29.9M0-
Total Cash454M17M2,671%
Total Debt64.5M0-
FUNDAMENTALS RATINGS
AUTL vs SYBX: Fundamental Ratings
AUTL
SYBX
OUTLOOK RATING
1..100
5777
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
85
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9154
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AUTL's Valuation (20) in the Biotechnology industry is somewhat better than the same rating for SYBX (85). This means that AUTL’s stock grew somewhat faster than SYBX’s over the last 12 months.

AUTL's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SYBX (100). This means that AUTL’s stock grew similarly to SYBX’s over the last 12 months.

AUTL's SMR Rating (100) in the Biotechnology industry is in the same range as SYBX (100). This means that AUTL’s stock grew similarly to SYBX’s over the last 12 months.

SYBX's Price Growth Rating (54) in the Biotechnology industry is somewhat better than the same rating for AUTL (91). This means that SYBX’s stock grew somewhat faster than AUTL’s over the last 12 months.

SYBX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as AUTL (100). This means that SYBX’s stock grew similarly to AUTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AUTLSYBX
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 4 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 11 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNTH24.810.57
+2.35%
Dianthus Therapeutics
OXSQ2.200.01
+0.46%
Oxford Square Capital Corp
CNO39.42-0.19
-0.48%
CNO Financial Group
WEC106.31-1.37
-1.27%
WEC Energy Group
ORKT0.70-0.01
-1.42%
Orangekloud Technology Inc

AUTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with OCUL. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUTL
1D Price
Change %
AUTL100%
N/A
OCUL - AUTL
49%
Loosely correlated
+1.62%
CRSP - AUTL
44%
Loosely correlated
-0.90%
LRMR - AUTL
44%
Loosely correlated
+0.26%
SCPH - AUTL
43%
Loosely correlated
-0.18%
IMCR - AUTL
41%
Loosely correlated
-1.26%
More

SYBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYBX has been loosely correlated with NEUP. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if SYBX jumps, then NEUP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYBX
1D Price
Change %
SYBX100%
-0.68%
NEUP - SYBX
64%
Loosely correlated
+19.47%
BTAI - SYBX
37%
Loosely correlated
+3.54%
SBHMY - SYBX
34%
Loosely correlated
N/A
MDGL - SYBX
31%
Poorly correlated
+2.85%
AUTL - SYBX
29%
Poorly correlated
N/A
More